ArticleResearch and practice in thrombosis and haemostasis2023

Corrigendum to 'Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis' [Research and Practice in Thrombosis and Haemostasis, Volume 7, Issue 2, February 2023, 100077].

Steven W Pipe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.